Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Serum Metabolism In Vivo using Non-Targeted Metabolomics Analysis

ABSTRACT:

ORGANISM(S): Mus Musculus

TISSUE(S): Blood

DISEASE(S): Cancer

PROVIDER: ST000895 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	mwtab	Other

Items per page:

1 - 1 of 1

Similar Datasets

Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo.

Project description: Not available

| S-EPMC5618316 | biostudies-literature

Targeting Bruton tyrosine kinase using non-covalent inhibitors in B cell malignancies.

Project description: Not available

| S-EPMC7937220 | biostudies-literature

Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis.

Project description: Not available

| S-EPMC5727336 | biostudies-literature

Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors.

Project description: Not available

| S-EPMC8007737 | biostudies-literature

Taste and smell disturbances in patients with gastrointestinal stromal tumors using tyrosine-kinase inhibitors.

Project description:Interventions: Patients will be interviewed by phone about taste alterations. Information about the background of the patients, including gender, age and type and treatment of the GIST, will be collected from the patients electronic file. Primary outcome(s): What is the prevalence of taste and smell disturbances in GIST patients using TKIs? Study Design: N/A: single arm study, Open (masking not used), N/A , unknown, Other

| 2442363 | ecrin-mdr-crc

Effects of the Kinase Inhibitor Sorafenib on Serum Metabolism In Vivo using Non-targeted Metabolomics Analysis tissue).

Project description: Not available

| ST000574 | MetabolomicsWorkbench

Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer.

Project description: Not available

| S-EPMC8798861 | biostudies-literature

Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma.

Project description: Not available

| S-EPMC8308832 | biostudies-literature

Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Muscle Metabolism In Vivo

Project description: Not available